Metropolis Healthcare Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹877 - ₹880
- Lot size
- 17 shares
- Issue amount
- ₹1,204 cr
- Total subscription
- 0×
- Opens
- 3 Apr 2019
- Closes
- 5 Apr 2019
- Allotment
- 10 Apr 2019
- Listing
- 15 Apr 2019
Offer at a glance
Issue overview
- Issue size
- 1,36,85,095 shares
- Face value
- ₹2 per share
- Minimum investment
- ₹14,909
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹0 cr
- Registrar
- Link Intime India Private Ltd
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,960
- Issue type
- Bookbuilding IPO
- Shares before issue
- 5,01,78,680
- Shares after issue
- 5,01,78,680
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 17 | ₹14,960 |
| sHNI | 14 | 238 | ₹2,09,440 |
| bHNI | 67 | 1,139 | ₹10,02,320 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
in Lakhs · Reported periods may include interim results.
Company information
Company profile
Incorporated in 1980, Mumbai-based Metropolis Healthcare Limited is a chain of diagnostic companies operating 106 clinical laboratories and 1,130 collection centers across seven countries, with a presence in 18 states and 173 cities in India for disease monitoring, early detection, and diagnostic screening. The company offers 3,480 clinical laboratory tests and 524 profiles, combining various tests for specific diseases, and serves around 7.7 million patients annually, conducting approximately 16 million tests. It also provides analytical and support services for clinical research projects and follows a 'hub and spoke' model to enhance service delivery. Internationally, Metropolis has laboratory operations in Ghana, Zambia, Kenya, Sri Lanka, and Mauritius, and offers third-party services in UAE, Nepal, Nigeria, and Oman. The company has been recognized for excellence in customer service and delivery by Biotrains, for service excellence by FICCI, and as "best in health and fitness" by LH Insights in 2018.
Strengths
- Industry-Ready: Well-positioned to benefit from expected industry growth.
- Widespread Operations: Extensive operational network across regions.
- Comprehensive Test Menu: Offers a broad range of testing services.
- Quality & Service Focus: Emphasizes high-quality standards and customer satisfaction.
- Strong IT Infrastructure: Robust technology systems supporting operations.
Promoters
Dr Sushil Kanubhai Shah
Ameera Sushil Shah
Metz Advisory LLP
Registrar & documents
Lead manager
Credit Suisse Securities (India) Private Limited, Goldman Sachs (India) Securities Private Limited, Hdfc Bank Limited, Jm Financial Limited, Kotak Mahindra Capital Company
Registrar & contacts
Link Intime India Private Ltd
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
250 D Udyog Bhavan, Hind Cycle Marg, Worli Mumbai 400 030, Maharashtra
(91 22) 6258 2810
[email protected]Company website ↗Understanding METROPOLIS IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.